Immune checkpoint inhibitors for patients with gene-rearranged non-small cell lung cancer

被引：1
|
作者：
Uehara, Yuji [1 ,2 ]
Hakozaki, Taiki [1 ,3 ,4 ]
机构：
[1] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Thorac Oncol & Resp Med, Tokyo, Japan
[2] Tokyo Med & Dent Univ, Ctr Innovat Canc Treatment, Grad Sch Med & Dent Sci, Dept Precis Canc Med, Tokyo, Japan
[3] Waseda Univ, Fac Sci & Engn, Grad Sch Adv Sci & Engn, Tokyo, Japan
[4] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Thorac Oncol & Resp Med, 3-18-22 Honkomagome, Bunkyo, Tokyo, Japan
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2023年 / 12卷 / 01期
关键词：
Immune checkpoint inhibitor (ICI); non-small cell lung cancer (NSCLC); gene rearrangement; biomarker; prognosis; OUTCOMES; IMMUNOTHERAPY; MUTATIONS; EFFICACY; BLOCKADE; NSCLC;
D O I：
10.21037/tlcr-22-872
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6 / 10
页数：5
相关论文
共 50 条
  • [31] Efficacy and tolerance of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung disease
    Matsumoto, Kinnosuke
    Adachi, Yuichi
    Enomoto, Takatoshi
    RESPIROLOGY, 2020,
  • [32] Analysis of immune checkpoint inhibitors for advanced non-small cell lung cancer in patients receiving antacids
    Isono, Taisuke
    Furuno, Hajime
    Onodera, Yoko
    Maruyama, Tomoya
    Takeuchi, Yuki
    Kojima, Ayaka
    Nishida, Takashi
    Kobayashi, Yoichi
    Ishiguro, Takashi
    Takaku, Yotaro
    Kurashima, Kazuyoshi
    Kagiyama, Naho
    RESPIRATORY INVESTIGATION, 2024, 62 (06) : 951 - 959
  • [33] Explore the efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients of different gender
    Zheng, S-Y.
    Cui, H-J.
    ANNALS OF ONCOLOGY, 2020, 31 : S715 - S715
  • [34] Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients' selection
    Banna, Giuseppe Luigi
    Passiglia, Francesco
    Colonese, Francesca
    Canova, Stefania
    Menis, Jessica
    Addeo, Alfredo
    Russo, Antonio
    Cortinovis, Diego Luigi
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 129 : 27 - 39
  • [35] Prognostic effect of cachexia in patients with non-small cell lung cancer receiving immune checkpoint inhibitors
    Matsuo, Norikazu
    Azuma, Koichi
    Murotani, Kenta
    Murata, Daiki
    Matama, Goushi
    Kawahara, Akihiko
    Kojima, Takashi
    Tokito, Takaaki
    Hoshino, Tomoaki
    THORACIC CANCER, 2023, 14 (15) : 1362 - 1367
  • [36] Evaluating the effect of immune checkpoint inhibitors on venous thromboembolism in non-small cell lung cancer patients
    He, Xin
    Wei, Shan-Na
    Qin, Wen-Wen
    Geng, Nan
    Li, Bin
    Song, Shan
    Wang, Ping
    EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (12) : 1135 - 1142
  • [37] Patterns of Failure in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
    Chai, Rong
    Yin, Yipengchen
    Cai, Xuwei
    Fu, Xiaolong
    Zhang, Qin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [38] Hyperprogressive disease in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors
    Ayala de Miguel, P.
    Lopez Gallego, J.
    Gorospe Garcia, I.
    Illan Varella, A.
    Rivera Vargas, P. R.
    Posada Restrepo, A.
    Borrega Garcia, P.
    ANNALS OF ONCOLOGY, 2019, 30
  • [39] Sex differences in tolerability and response to immune checkpoint inhibitors in non-small cell lung cancer patients
    Duma, Narjust
    Azzouqa, Abdel-Ghani
    Yadav, Siddhartha
    Hoversten, Kahterine
    Reed, Clay
    Sitek, Andrea
    Enninga, Elizabeth
    Paludo, Jonas
    Kottschade, Lisa
    Mansfield, Aaron
    Manochakian, Rami
    Dronca, Roxana
    Adjei, Alex
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
  • [40] Safety of Palliative Radiotherapy and Immune Checkpoint Inhibitors in Patients with Metastatic Non-Small Cell Lung Cancer
    Tjong, M.
    Ragulojan, M.
    Poon, I.
    Cheng, S.
    Doherty, M.
    Ung, Y.
    Cheung, P.
    Cheema, P.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S667 - S668
12345